Catalent plans to quadruple cold-chain capacity at its existing clinical supply storage and distribution facility in Shanghai, China. The expansion is in response to growing customer demand from both domestic and multinational pharmaceutical sponsors and contract research organizations..

Expansion work at the site is underway and is due to be fully validated and operational by the end of the year. Opened in 2013, the facility provides end-to-end clinical supply solutions from clinical supply management, comparator/reference product sourcing and primary packaging to clinical storage and distribution.The cGMP site is also validated to support biologics requiring refrigerated and frozen supply chain management and currently offers 15 ºC/25 ºC controlled room temperature, 2 ºC/8 ºC refrigerated, -20 ºC frozen and -80 ºC ultra-low frozen storage environments. The new expansion includes the quadrupling of existing cold-chain storage capacity, as well as new dedicated receiving, dispatch and packaging areas.

Catalent also announced that it had added further packaging and low temperature storage capacity to its Singapore facility, citing the need to support secondary packaging and innovative and flexible clinical supply services. “This expansion follows the company’s announcement in June 2015 that it is increasing capacity at its Singapore clinical supply facility by 60%.

Catalent’s clinical supply services organization has facilities in the US, UK, Germany, Singapore and China, and a network of over 50 audited depots,

Source: Catalent